Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer
Xiaoqing Jia(Fudan University Shanghai Cancer Center), Guang‐Yu Liu(Shanghai Medical College of Fudan University)
Cited by 37
Related Papers
Zoledronic acid sensitizes breast cancer cells to fulvestrant via ERK/HIF-1 pathway inhibition in�vivo
|Molecular Medicine Reports|2018|5